TABLE 1.
Prevalence rates of indeterminate and positive serological HIV results obtained with the Determine and Genie II rapid assays according to a sequential algorithma
| HIV rapid testing result | No. of results (%) |
P | |||
|---|---|---|---|---|---|
| 2005 (n = 12,592) | 2006 (n = 15,725) | 2007 (n = 16,336) | Total (n = 44,653) | ||
| Indeterminate (Determine positive, Genie II negative) | 152 (1.21) | 213 (1.35) | 232 (1.42) | 597 (1.34) | 0.29 |
| Positive (Determine positive, Genie II positive)b | 554 (4.40) | 623 (3.96) | 726 (4.44) | 1,903 (4.26) | 0.07 |
| HIV-1 | 519 (4.12) | 576 (3.66) | 681 (4.17) | 1,776 (3.98) | 0.04 |
| HIV-2 | 19 (0.15) | 22 (0.14) | 17 (0.10) | 58 (0.13) | 0.50 |
| HIV-1 + 2 | 16 (0.13) | 25 (0.16) | 28 (0.17) | 69 (0.15) | 0.63 |
a
Prevention of mother-to-child transmission (PMTCT) Kesho Bora trial, Bobo-Dioulasso, Burkina Faso (2005-2007).
b
The differentiation between HIV-1 and HIV-2 was achieved by using the Genie II test (see Materials and Methods).